Parnell Pharmaceuticals Holdings Ltd
PARNF · OTC
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $4 | $4 | $5 | $4 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $2 | $1 | $0 | $2 |
| Inventory | $4 | $4 | $2 | $3 |
| Other Curr. Assets | $1 | $3 | $3 | $1 |
| Total Curr. Assets | $12 | $12 | $10 | $10 |
| Property Plant & Equip (Net) | $13 | $14 | $16 | $11 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $15 | $14 | $0 | $13 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $14 | $0 |
| Total NC Assets | $28 | $29 | $29 | $24 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $40 | $41 | $39 | $33 |
| Liabilities | – | – | – | – |
| Payables | $5 | $5 | $6 | $4 |
| Short-Term Debt | $1 | $1 | $6 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $7 | $7 | $4 | $3 |
| Total Curr. Liab. | $12 | $13 | $16 | $7 |
| LT Debt | $63 | $59 | $49 | $45 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $63 | $60 | $49 | $45 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $5 | $5 | $6 | $0 |
| Total Liabilities | $75 | $72 | $65 | $52 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $68 | $64 | $64 | $0 |
| Retained Earnings | -$102 | -$101 | -$85 | -$78 |
| AOCI | -$1 | $5 | -$4 | -$7 |
| Other Equity | -$0 | -$0 | -$0 | $3 |
| Total Equity | -$35 | -$32 | -$26 | -$19 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $40 | $41 | $39 | $33 |
| Net Debt | $59 | $56 | $51 | $41 |